Trump accuses FDA and Democrats of holding back Covid vaccine until after election

Pfizer announced drug success days after president defeated

Graeme Massie
Los Angeles
Tuesday 10 November 2020 01:17
Comments
Coronavirus in numbers

Donald Trump has accused the FDA and Democrats of holding back a Covid-19 vaccine until after the election.

Mr Trump took to Twitter to attack his opponents and accuse them of manipulating the virus response to harm his re-election chances.

On Monday drug maker Pfizer announced that early data from its coronavirus vaccine trial shows it is more than 90 per cent effective.

The news came just days after Mr Trump was beaten at the polls by president-elect Joe Biden.

“The @US_FDA and the Democrats didn’t want to have me get a Vaccine WIN, prior to the election, so instead it came out five days later – As I’ve said all along!” Mr Trump wrote on Twitter.

The company says it will have enough doses of the vaccine to give to between 15 million and 20 million people by the end of the year. 

Mr Trump had repeatedly said on the campaign trail that a vaccine would be ready by election day.

“This is a historical moment,” said Kathrin Jansen, a senior vice president and the head of vaccine research and development at Pfizer.

 "This was a devastating situation, a pandemic, and we have embarked on a path and a goal that nobody ever has achieved — to come up with a vaccine within a year."

Pfizer have denied any allegations that politics played a part in the timing of their announcement. 

More than 74 million Americans cast votes for president-elect Joe Biden, while more than 70 million voted for Mr Trump, with 65 per cent of eligible voters taking part in the election.

Mr Biden’s victory was achieved by rebuilding the “blue wall” of Wisconsin, Michigan and Pennsylvania, while flipping the battleground states of Arizona and Georgia.

His victory in Georgia is narrow enough that it will require a recount.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in